These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 11513169

  • 1. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L, Chaumette MT, Haioun C.
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 3. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH, Chen LT, Wu MS, Kuo KT, Yeh KH, Doong SL, Yeh PY, Hsu HC, Tzeng YS, Lin CW, Lin JT, Cheng AL.
    J Pathol; 2007 Feb 21; 211(3):296-304. PubMed ID: 17167822
    [Abstract] [Full Text] [Related]

  • 4. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
    Watanobe I, Takamori S, Kojima K, Fukasawa M, Beppu T, Futagawa S, Hirai S.
    J Gastroenterol; 2002 Feb 21; 37(9):691-6. PubMed ID: 12375141
    [Abstract] [Full Text] [Related]

  • 5. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, de Mascarel A, Hemery F, Gaulard P, Delchier JC, Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Am J Gastroenterol; 2002 Feb 21; 97(2):292-7. PubMed ID: 11866264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas.
    Peng H, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, Pan L.
    J Pathol; 1998 Aug 21; 185(4):409-12. PubMed ID: 9828840
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M.
    J Physiol Pharmacol; 2001 Aug 21; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [Abstract] [Full Text] [Related]

  • 9. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, Starzynska T, Marlicz K, Popiela T, Hartwich A, Hahn EG.
    J Physiol Pharmacol; 1999 Dec 21; 50(5):857-73. PubMed ID: 10695565
    [Abstract] [Full Text] [Related]

  • 10. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M.
    Rev Esp Enferm Dig; 1999 Aug 21; 91(8):541-8. PubMed ID: 10491486
    [Abstract] [Full Text] [Related]

  • 11. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
    Iwano M, Watanabe N, Matsushima Y, Seno H, Oki K, Sakurai T, Inagaki H, Okazaki K, Chiba T.
    Am J Gastroenterol; 2006 Dec 21; 101(12):2878-83. PubMed ID: 17026570
    [Abstract] [Full Text] [Related]

  • 12. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 21; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]

  • 13. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
    Mitchell HM, Hazell SL, Li YY, Hu PJ.
    Am J Gastroenterol; 1996 Sep 21; 91(9):1785-8. PubMed ID: 8792699
    [Abstract] [Full Text] [Related]

  • 14. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
    Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H.
    Helicobacter; 2006 Apr 21; 11(2):86-95. PubMed ID: 16579838
    [Abstract] [Full Text] [Related]

  • 15. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, Serraino D, Poletti M, Carbone A.
    Am J Gastroenterol; 1998 Mar 21; 93(3):375-9. PubMed ID: 9517643
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
    Saruç M, Demir MA, Küçükmetin N, Kandiloglu AR, Akarca US, Yüceyar H.
    Hepatogastroenterology; 2002 Mar 21; 49(45):878-81. PubMed ID: 12064012
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease.
    Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, Morgner A, Stolte M, Ehninger G, Bayerdörffer E.
    Am J Gastroenterol; 2001 Apr 21; 96(4):1008-13. PubMed ID: 11316139
    [Abstract] [Full Text] [Related]

  • 20. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 21; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.